Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3009347	s-ld-is	— (—)	205	219	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant melanoma, including Hilmo

9.03

22.06

1.1

—

Liquid cancers, helper endpoint

6.55

21.30

1.2

1.0

—

Malignant melanoma

9.00

21.18

1.1

—

Melanoma of uvea

+∞

18.91

1.1

0.0

—

Malignant neoplasm of eye and adnexa, including Hilmo

+∞

18.85

1.1

0.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

127

3.53

17.55

1.1

—

Heart failure and coronary heart disease

5.47

16.95

1.1

1.0

—

Other and unspecified anaemias

4.71

16.55

1.1

—

Other anaemias

4.70

16.49

1.1

—

Aplastic and other anaemias

4.44

15.72

1.1

—

Valvular heart disease excluding rheumatic fever

5.16

15.28

1.1

—

Non-rheumatic valve diseases

5.16

15.26

1.1

—

Bacterial infection, other or unspecified

3.84

14.30

1.0

1.1

—

Fever of other and unknown origin

3.83

12.23

1.0

1.1

—

Bacterial infection, other or unspecified

3.56

11.58

1.0

1.1

—

Other bacterial diseases

135

2.84

10.98

1.1

—

Anaemias

11.06

10.89

1.0

—

All kidney diseases

133

2.78

10.07

1.1

—

Other bacterial diseases

133

2.72

10.03

1.1

—

Heart failure,strict

3.69

9.99

1.0

1.1

—

Heart failure, strict

3.44

9.83

1.0

1.1

—

All pneumoniae

140

2.67

9.71

1.0

1.1

—

All-cause Heart Failure

3.44

9.58

1.0

1.1

—

Renal tubulo-interstitial diseases

130

2.81

9.57

1.1

—

Renal failure

3.45

9.17

1.2

1.0

—

Heart failure, not strict

102

2.93

9.04

1.1

1.0

—

Oral corticosteroids

127

2.62

9.04

1.1

—

Presence of cardiac and vascular implants and grafts

3.60

8.98

1.1

1.0

—

Non-invasive ventilation

7.22

8.98

1.1

1.0

—

All chronic kidney diseases

3.37

8.96

1.2

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

4.32

8.85

1.1

1.0

—

General symptoms and signs

103

2.68

8.77

1.1

1.0

—

Covid-19 confirmed case

3.77

8.76

1.0

1.1

—

Oedema, not elsewhere classified

4.26

8.66

1.1

—

Emergency coronary revascularization (for ACS)

100

2.80

8.47

1.1

1.0

—

Malignant neoplasm of eye and adnexa

+∞

8.37

1.3

0.0

—

Persons encountering health services for specific procedures and health care

131

2.52

8.30

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

141

2.52

8.29

1.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

119

2.54

8.12

1.1

—

Other diseases of pleura

3.29

8.01

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

114

2.60

7.92

1.0

1.1

—

114

2.60

7.92

1.0

1.1

—

Inflammatory bowel disease treatment related agents

128

2.45

7.85

1.1

—

Coronary revascularization (ANGIO or CABG)

2.77

7.83

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

144

2.46

7.80

1.0

1.1

—

Influenza and pneumonia

137

2.46

7.78

1.0

1.1

—

Major coronary heart disease event

2.71

7.68

1.1

1.0

—

First line medication for Crohn's disease

115

2.49

7.62

1.1

—

ILD medications

120

2.44

7.47

1.1

—

Percutaneous Coronary Intervention

2.71

7.38

1.0

—

Malignant neoplasm, wide definition for exclusion

2.68

7.13

1.1

—

Malignant neoplasm

2.67

6.93

1.1

—

Pneumonia, organism unspecified

134

2.41

6.68

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

131

2.28

6.65

1.1

—

Dental caries

4.19

6.55

1.0

1.1

—

Acute renal failure

4.15

6.54

1.1

1.0

—

Heart failure and bmi 25plus

3.97

6.44

1.1

—

Any event in cancer register

2.50

6.30

1.1

—

Dyspnoea

143

2.33

6.18

1.1

—

Bacterial Sepsis

2.88

6.06

1.0

1.1

—

Neoplasms

3.00

6.02

1.1

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

130

2.30

6.01

1.1

—

Chronic kidney disease

3.32

5.92

1.2

1.0

—

Glaucoma

100

2.67

5.85

1.2

1.1

—

Solid cancers, helper endpoint

2.52

5.83

1.1

—

Pacemaker

3.20

5.81

1.0

1.1

—

Any death

2.60

5.67

1.0

1.1

—

Other medical care

2.85

5.61

1.1

—

Disorders of eyelid, lacrimal system and orbit

140

2.28

5.58

1.1

—

Pleural effusion

5.01

5.55

1.1

1.0

—

Care involving use of rehabilitation procedures

117

2.52

5.48

1.1

—

Conduction disorders

3.93

5.42

1.0

1.1

—

Haemolytic anaemias

16.09

5.41

1.0

—

Implicit bacterial Sepsis

2.84

5.35

1.0

1.1

—

Myocardial infarction

3.02

5.34

1.1

1.0

—

Symptoms and signs concerning food and fluid intake

9.09

5.27

1.3

1.0

—

Other arrhythmias

2.60

5.26

1.2

1.1

—

ILD medications: immunosuppressive drugs

110

2.53

5.24

1.1

—

Other autoimmune haemolytic anaemias

+∞

5.22

1.0

0.0

—

Persons encountering health services in other circumstances, wide

131

2.08

5.18

1.1

—

Implicit bacterial Sepsis

2.71

5.08

1.0

1.1

—

Myocardial infarction, strict

3.07

5.08

1.1

1.0

—

Secondary uncertain malignant neoplasm

5.20

5.07

1.1

—

Caries of dentine

4.45

5.02

1.0

1.1

—

Codes for special purposes

116

2.50

5.00

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

116

2.50

5.00

1.0

1.1

—

Septicaemia

2.83

4.97

1.0

1.1

—

Asthma, unspecified (mode), excluding more controls

2.87

4.82

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

4.84

4.80

1.1

—

Implicit Sepsis

130

2.19

4.75

1.0

1.1

—

Ischemic heart diseases

101

2.26

4.73

1.1

1.0

—

Iron deficiency anaemia

2.70

4.62

1.2

1.1

—

Heart failure and antihypertensive medication

3.61

4.55

1.0

—

Acute tubulo-interstitial nephritis

109

2.38

4.55

1.0

1.1

—

Fibrosis and cirrhosis of liver

6.68

4.46

1.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes

6.68

4.46

1.0

1.1

—

Other pleural conditions

5.80

4.43

1.2

1.1

—

Enlarged lymph nodes

5.80

4.43

1.1

—

Venous thromboembolism

113

2.39

4.42

1.1

—

Erysipelas

111

2.27

4.42

1.1

—

Systemic connective tissue disorders

2.82

4.37

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

127

2.25

4.37

1.1

—

Asthma (only as main-diagnosis), excluding more controls

2.57

4.35

1.1

—

Any gastric operation

2.43

4.30

1.0

—

GASTRO-related operations

2.43

4.30

1.0

—

Infections, IBD-co-morbidities

6.05

4.29

1.0

—

Calcific aortic valvular stenosis, operated

2.96

4.26

1.0

1.1

—

Calcific aortic valvular stenosis

2.96

4.26

1.0

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.96

4.26

1.0

1.1

—

Operations 2 for CAVS

2.96

4.26

1.0

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

2.96

4.25

1.0

1.1

—

Hard cardiovascular diseases

102

2.16

4.20

1.1

1.0

—

Diseases of oesophagus, stomach and duodenum

140

1.96

4.10

1.2

1.0

—

DVT of lower extremities and pulmonary embolism

2.58

4.09

1.0

1.1

—

Angina pectoris

2.48

4.07

1.2

1.0

—

Cirrhosis of liver, NAS

8.03

4.06

1.0

1.1

—

All influenza

3.19

4.04

1.0

1.1

—

Episodal and paroxysmal disorders

126

1.94

3.97

1.1

1.0

—

Erysipelas

103

2.32

3.95

1.1

—

AV-block

4.58

3.94

1.0

1.1

—

Non-Hodgkin lymphoma, all, including Hilmo

4.45

3.93

1.0

1.1

—

Abnormalities of breathing

110

2.06

3.92

1.1

—

Diseases of liver

2.72

3.91

1.1

—

Malignant neoplasm of skin

2.54

3.84

1.0

1.1

—

Implicit Sepsis

127

2.08

3.83

1.0

1.1

—

Dialysis, with operation codes

5.27

3.82

1.0

1.1

—

Non-Hodgkin lymphoma, all

12.04

3.76

1.0

—

Explicit Sepsis

2.48

3.74

1.0

1.1

—

Asthma, unspecified (mode)

2.47

3.73

1.1

—

Autoimmune diseases excluding thyroid diseases

120

1.96

3.73

1.0

—

Other systemic involvement of connective tissue (FG)

3.02

3.71

1.1

—

Diseases of the eye and adnexa

2.25

3.70

1.1

1.0

—

Complications of surgical and medical care, not elsewhere classified

154

1.91

3.69

1.1

—

Hypertensive diseases (excluding secondary)

2.61

3.69

1.1

1.0

—

Valvular operations

5.63

3.65

1.0

1.1

—

Coronary artery bypass grafting

3.26

3.63

1.1

1.0

—

Asthma (only as main-diagnosis)

2.28

3.60

1.1

—

Other systemic involvement of connective tissue

2.94

3.56

1.1

1.0

—

Weight loss

4.77

3.55

1.1

1.0

—

Certain infectious and parasitic diseases

2.02

3.55

1.0

1.1

—

Other septicaemia

2.57

3.53

1.0

1.1

—

Soft tissue disorders

119

1.90

3.51

1.1

1.0

—

Nutritional anaemias

101

2.29

3.50

1.2

1.1

—

Unspecified haematuria

2.40

3.45

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

140

1.92

3.42

1.0

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

149

2.04

3.41

1.1

—

Malaise and fatigue

2.39

3.41

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

2.66

3.38

1.0

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

3.75

3.38

1.0

1.1

—

Coronary atherosclerosis

2.19

3.37

1.1

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

5.01

3.37

1.1

—

Bleeding

131

1.95

3.35

1.1

—

Asthma (mode)

2.19

3.34

1.1

—

Abnormal findings on diagnostic imaging of lung

103

2.23

3.31

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

127

2.05

3.31

1.2

1.1

—

Diffuse large B-cell lymphoma

8.60

3.26

1.0

—

Diffuse large B-cell lymphoma, including Hilmo

8.60

3.26

1.0

—

Diffuse large B-cell lymphoma, helper endpoint

8.60

3.26

1.0

—

Other metabolic disorders

4.74

3.23

1.1

—

Adjustment and management of implanted device

3.34

3.21

1.1

—

Sulfasalazine

2.86

3.18

1.3

1.1

—

Malignant melanoma of skin, including Hilmo

3.80

3.18

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

133

1.91

3.15

1.0

1.1

—

Parasetamol

2.11

3.15

1.1

1.0

—

Diseases of the digestive system

2.26

3.15

1.1

—

Pulmonary embolism

2.62

3.12

1.0

1.1

—

Pulmonary heart disease

2.62

3.12

1.0

1.1

—

Bacterial pneumonia (organism specified)

2.24

3.05

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

2.22

3.05

1.1

1.0

—

Finngen Rheumatological endpoints

123

1.85

3.05

1.1

1.0

—

Other and unspecified iron deficiency

2.50

3.03

1.2

1.1

—

Hypothyroidism, levothyroxine purchases

4.35

2.99

1.3

1.0

—

Hypothyroidism and >3 levothyroxin purchases

4.35

2.99

1.3

1.0

—

Intracranial trauma

2.27

2.99

1.1

1.0

—

Hypothyroidism (congenital or acquired)

4.35

2.99

1.3

1.0

—

Other CVD (FINNGEN)

5.17

2.99

1.0

1.1

—

Bacterial pneumoniae

2.32

2.98

1.1

—

Somatoform disorder

3.85

2.97

1.0

1.1

—

Complications of procedures, not elsewhere classified

144

1.90

2.94

1.1

—

Asthma-related pneumonia

2.46

2.94

1.1

—

Asthma-related pneumonia or sepsis

2.46

2.94

1.1

—

Asthma, hospital admissions 3, pneumonia

2.46

2.94

1.1

—

Transplanted organ and tissue status

4.71

2.91

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

2.16

2.90

1.0

1.1

—

Any reimbursement code in KELA

2.51

2.87

1.1

—

Endometriosis

2.68

2.87

1.3

1.1

—

Other symptoms and signs involving the circulatory and respiratory systems

5.39

2.87

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

6.68

2.86

1.0

—

Asthma, excluding more controls

2.17

2.85

1.1

—

Non-allergic asthma (mode), excluding more controls

4.05

2.85

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.19

2.83

1.1

—

Disorders of lacrimal system

2.28

2.81

1.3

1.1

—

Other diseases of intestine

3.34

2.80

1.0

1.1

—

Strabismus

2.76

2.79

1.0

1.1

—

Other infectious diseases

4.45

2.79

1.0

1.1

—

Rheumatism, unspecified

3.92

2.77

1.0

—

Primary open-angle glaucoma

2.54

2.76

1.1

1.0

—

Other soft tissue disorders, not elsewhere classified

119

1.82

2.75

1.1

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.20

2.74

1.1

1.0

—

Autoimmune diseases

121

1.77

2.73

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

119

1.79

2.72

1.0

—

Other specified/unspecified arthritis

2.71

1.1

—

Septal defects

8.17

2.71

1.0

—

Certain infectious and parasitic diseases

2.03

2.71

1.0

1.1

—

Bacterial pneumonia, not elsewhere classified

2.26

2.70

1.0

1.1

—

Gastro-oesophageal reflux disease

125

1.93

2.68

1.2

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

4.22

2.67

1.1

—

Nephropathy related operations

3.75

2.67

1.0

—

Gastrointestinal diseases

2.29

2.67

1.0

—

Non-ischemic cardiomyopathy

2.62

2.63

1.0

—

Status post-ami

2.75

2.63

1.2

1.0

—

Other strabismus

3.13

2.62

1.0

1.1

—

Ascites

4.67

2.59

1.0

1.1

—

Glaucoma, exfoliation

3.60

2.57

1.0

—

Non-follicular lymphoma

4.01

2.56

1.0

1.1

—

Other diseases of intestines

131

1.74

2.55

1.1

—

Kidney transplant status

7.16

2.55

1.0

—

Other arthritis (FG)

2.42

2.53

1.1

1.0

—

Nonsuppurative otitis media

3.07

2.53

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.39

2.52

1.3

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3.23

2.51

1.0

1.1

—

Opioids

108

1.78

2.50

1.0

1.1

—

Vocal cord dysfunction

4.49

2.48

1.1

1.0

—

Abnormal weight loss

3.82

2.46

1.1

1.0

—

Alzheimer’s disease, strict definition

0.00

2.45

0.0

1.1

—

Other pulmonary diagnosis

1.95

2.45

1.1

—

Non-allergic asthma (mode)

3.43

2.45

1.0

1.1

—

Benign neoplasm: Colon

117

1.96

2.44

1.1

—

Cardiac arrhythmias

2.07

2.41

1.2

1.0

—

Disorders of choroid and retina

132

1.78

2.39

1.1

—

Convulsions, not elsewhere classified

3.09

2.39

1.0

1.1

—

Fall on same level

145

1.66

2.38

1.1

—

Traumatic subdural haemorrhage

3.32

2.37

1.0

1.1

—

Other heart diseases, wide

104

1.82

2.36

1.1

—

Other infectious diseases

4.12

2.36

1.0

1.1

—

ILD, hospital admissions 3, with pneumonia sepsis

4.12

2.36

1.0

1.1

—

Contact with machinery

4.12

2.36

1.0

1.2

—

Endometriosis of ovary

3.25

2.32

1.3

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3.23

2.30

1.0

—

Used for control exclusion in common control thyroid runs

112

1.71

2.28

1.1

1.0

—

Congenital malformations of heart and great arteries

3.53

2.28

1.0

—

Infections of the skin and subcutaneous tissue

125

1.90

2.28

1.1

1.0

—

Myocardial infarction, without ST-elevation

2.09

2.28

1.2

1.0

—

Benign neoplasms

119

1.71

2.27

1.1

1.0

—

Hypertensive diseases

101

1.79

2.27

1.2

1.0

—

Alzheimer’s disease (Late onset)

0.00

2.27

0.0

1.1

—

Hypertension

101

1.79

2.27

1.2

1.0

—

Glaucoma suspect

2.22

2.27

1.3

1.1

—

Malignant melanoma of skin

3.48

2.27

1.1

—

Injuries to unspecified part of trunk, limb or body region

3.48

2.27

1.0

—

Foreign body on external eye

3.48

2.26

1.0

1.1

—

Other functional intestinal disorders

2.07

2.26

1.0

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.13

2.24

1.0

—

Asthma

1.92

2.23

1.1

—

Atrial fibrillation and flutter

2.56

2.23

1.0

—

Neurological diseases

1.81

2.23

1.1

1.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.56

2.21

1.0

—

Tramadol

103

1.79

2.18

1.1

—

Injuries to the head

159

1.62

2.18

1.1

—

Other and unspecified effects of external causes

2.50

2.18

1.3

1.0

—

Viral pneumonia

3.34

2.18

1.0

—

Polyarthropathies

1.84

2.16

1.1

1.0

—

Congenital malformations of cardiac septa

5.38

2.16

1.0

—

Hypoglycaemia, other or unspecified

4.29

2.15

1.3

1.1

—

Poor fetal growth

4.29

2.15

1.0

1.1

—

Myeloproliferative diseases

3.69

2.15

1.6

1.1

—

L04AD Calcineurin inhibitors

3.69

2.15

1.0

1.1

—

ILD medications: azathioprine

3.69

2.15

1.1

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3.01

2.14

1.0

—

Pain, not elsewhere classified

2.62

2.14

1.1

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

2.01

2.11

1.1

1.0

—

Intestinal infectious diseases

165

1.66

2.10

1.0

1.1

—

Disorders of lens

1.80

2.10

1.1

1.0

—

Rotator cuff syndrome

102

1.83

2.10

1.2

1.0

—

Viral infections characterized by skin and mucous membrane lesions

2.04

2.10

1.0

1.1

—

Diabetic nephropathy, excluding more controls

3.29

2.10

1.3

1.0

—

Cardiomyopathy

3.20

2.09

1.1

—

Other skin changes

2.56

2.07

1.3

1.0

—

Early onset COPD, excluding more controls

2.90

2.07

1.0

1.1

—

Open wound of ankle and foot

3.50

2.05

1.0

1.1

—

ILD, hospital admission 2, with pulmonary infections

3.50

2.05

1.0

1.1

—

Implicit viral Sepsis

2.32

2.04

1.0

1.1

—

malignant neoplasm of female genital organs

3.48

2.04

1.1

—

Sicca syndrome [Sjögren]

4.00

2.04

1.2

1.0

—

Cholelithiasis, broad definition with cholecystitis

137

1.67

2.02

1.1

—

Paroxysmal tachycardia

2.90

2.02

1.0

—

Hypothyroidism, drug reimbursement

4.24

2.02

1.5

1.0

—

Effects of foreign body entering through natural orifice

2.50

2.01

1.0

1.1

—

COPD differential diagnosis

1.83

1.97

1.1

—

ILD differential diagnosis

1.83

1.97

1.1

—

Azathioprine

3.34

1.96

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

113

1.85

1.96

1.0

1.1

—

Hypertension, essential

1.73

1.96

1.2

1.1

—

Retinal detachments and breaks

2.08

1.96

1.1

—

Acute suppurative otitis media

2.59

1.95

1.1

1.0

—

Other disorders of eyelid

1.95

1.94

1.0

1.1

—

Spontaneous rupture of synovium and tendon

4.55

1.94

1.2

1.0

—

Dermatophytosis

134

1.79

1.93

1.1

—

Other disorders of glucose regulation and pancreatic internal secretion

3.75

1.93

1.3

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.84

1.93

1.2

1.0

—

Other diseases of blood and blood-forming organs, wide

2.45

1.92

1.2

1.0

—

Other retinal disorders

115

1.76

1.92

1.1

—

Other disorders of lacrimal gland

2.11

1.91

1.3

1.1

—

Excluding asthma or asthma-COPD overlap

1.81

1.90

1.1

—

Malignant neoplasm of breast, HER-negative

2.91

1.89

1.1

—

Amiodarone users

3.19

1.88

1.0

—

Benign neoplasm: Caecum

3.19

1.88

1.1

1.0

—

Factors influencing health status and contact with health services

2.51

1.87

1.1

1.0

—

Shoulder lesions

107

1.70

1.87

1.2

1.0

—

Other heart diseases

2.09

1.84

1.1

1.0

—

Divergent concomitant strabismus

3.53

1.83

1.0

1.1

—

Unspecified kidney failure

3.53

1.83

1.7

1.1

—

Metabolic disorders

137

1.60

1.83

1.0

1.1

—

Lymphoid leukaemia

4.17

1.82

1.4

1.1

—

Synovial cyst of popliteal space [Baker]

4.17

1.82

1.0

—

Hypertensive heart and/or renal disease

2.18

1.82

1.2

1.1

—

Sleep apnoea

141

1.61

1.81

1.1

—

Reimbursement for rheumatic diseases

122

1.80

1.81

1.2

1.1

—

Leisure time condition

2.57

1.80

1.1

1.0

—

Glomerular disorders in diseases classified elsewhere

3.05

1.80

1.3

1.0

—

Hypokalaemia

3.05

1.80

1.1

1.0

—

Type 2 diabetes, wide definition

120

1.65

1.79

1.1

—

Second line medication for Crohn's disease

123

1.79

1.1

—

Endometriosis of pelvic peritoneum

3.03

1.78

1.1

1.0

—

Syncope and collapse

2.01

1.78

1.1

—

Examination and observation for other reasons

1.84

1.78

1.1

1.0

—

Speech therapy

2.17

1.77

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.78

1.77

1.1

1.0

—

Lung cancer and mesothelioma

2.57

1.76

1.1

—

Other disorders of skin and subcutaneous tissue

143

1.68

1.74

1.2

1.1

—

Hydronephrosis

3.34

1.74

1.2

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.03

1.74

1.0

1.1

—

Sleep apnoea, including avohilmo

146

1.57

1.74

1.1

—

Congenital malformations of the circulatory system

2.95

1.73

1.0

—

L04AX Other immunosuppressants

117

1.79

1.73

1.1

—

Malignant neoplasm of rectum, including Hilmo

2.92

1.72

1.0

1.1

—

Benign neoplasm: Choroid

3.85

1.71

1.0

—

Invasive ventilation

3.85

1.71

1.2

1.1

—

Psychotic depression

3.85

1.71

1.0

—

Malignant neoplasm of corpus uteri, including Hilmo

3.85

1.71

1.2

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

139

1.68

1.71

1.0

1.1

—

Autoimmune diseases related-to ILD

165

1.61

1.70

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

2.29

1.70

1.3

1.0

—

Depression medications

2.87

1.69

1.1

1.0

—

Persons encountering health services in other circumstances

2.05

1.67

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.69

1.67

1.1

1.0

—

Endometriosis ASRM stages 3,4

2.50

1.66

1.3

1.1

—

Use of antiglaucoma preparations and miotics

3.16

1.66

1.3

1.0

—

Hypothyroidism, strict autoimmune

1.71

1.66

1.2

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

3.16

1.66

1.0

1.1

—

139

1.52

1.65

1.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2.47

1.65

1.0

1.1

—

Purpura and other haemorrhagic conditions

2.80

1.65

1.0

—

Coeliac disease

2.80

1.65

1.1

1.0

—

Dental operations

1.74

1.64

1.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

2.45

1.64

1.0

1.1

—

Concussion

1.95

1.63

1.0

—

Senile cataract

1.73

1.63

1.2

1.0

—

Basal cell carcinoma, including avohilmo

1.97

1.62

1.0

1.1

—

Malignant neoplasm of breast, ER-negative, including Hilmo

2.54

1.62

1.1

—

Pain in limb

114

1.64

1.61

1.1

1.0

—

Fall on and from ladder

3.58

1.61

1.0

1.1

—

Care involving dialysis

3.58

1.61

1.0

—

Complications of medical and surgical care

152

1.63

1.61

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.10

1.60

1.1

—

Symptoms and signs involving the digestive system and abdomen

120

1.54

1.58

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

110

1.77

1.58

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

145

1.55

1.58

1.2

1.0

—

Acute and transient psychotic disorders

3.00

1.58

1.2

1.1

—

Other bursopathies

3.00

1.58

1.0

—

Other and unspecified nonorganic psychotic disorders

2.69

1.58

1.1

—

Disorders of gallbladder, biliary tract and pancreas

148

1.53

1.57

1.0

1.1

—

Procreative management

2.01

1.56

1.0

1.1

—

Abnormalities of heart beat

1.99

1.56

1.1

—

Benign neoplasm: Rectum, anus and anal canal

2.27

1.55

1.3

1.0

—

Asthma, hospital admissions , main diagnosis only

161

1.59

1.55

1.1

—

Asthma/COPD (KELA code 203)

151

1.54

1.55

1.1

—

Chronic periodontitis, including avohilmo

153

1.53

1.54

1.1

—

Oxycodone

1.94

1.54

1.0

1.1

—

Falls/tendency to fall

129

1.51

1.54

1.1

—

Nontoxic multinodular goitre

2.43

1.53

1.1

1.0

—

Periodontitis

153

1.53

1.1

—

Colorectal adenocarcinoma

2.42

1.53

1.0

1.1

—

Dementia in Alzheimer disease

0.00

1.52

0.0

1.1

—

Osteonecrosis

3.34

1.52

1.2

1.1

—

Ulcerative rectosigmoiditis

3.34

1.52

1.0

1.1

—

Streptococcal septicaemia

3.34

1.52

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

130

1.69

1.52

1.0

1.1

—

Benign neoplasm of eye and adnexa

2.60

1.51

1.0

—

Basal cell carcinoma

1.96

1.51

1.0

1.1

—

Disorders of the thyroid gland

139

1.55

1.51

1.2

1.0

—

Seronegative rheumatoid arthritis

2.86

1.50

1.2

1.0

—

Colorectal cancer

2.45

1.48

1.0

1.1

—

Other bacterial intestinal infections

2.22

1.46

1.0

1.1

—

Hypertensive Heart Disease

2.09

1.46

1.1

—

Varicose veins

110

1.65

1.45

1.2

1.0

—

Retinal detachment with retinal break

2.50

1.45

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

153

1.51

1.44

1.0

1.1

—

Malignant neoplasm of bronchus and lung, including Hilmo

2.35

1.44

1.1

—

severe traumatic brain injury, does not include concussion

2.12

1.44

1.2

1.0

—

Noninfective enteritis and colitis

102

1.76

1.43

1.0

1.1

—

Ischaemic heart disease, wide definition

109

1.59

1.43

1.1

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

2.73

1.43

1.0

—

Fentanyl

2.72

1.43

1.0

1.1

—

Codeine

108

1.56

1.43

1.1

—

Other anxiety disorders

1.88

1.43

1.0

1.1

—

Osteopathies and chondropathies

109

1.71

1.43

1.2

1.1

—

Cardiovascular diseases

1.86

1.43

1.1

1.0

—

Glomerular diseases

2.31

1.42

1.2

1.0

—

Hypothyroidism, other/unspecified

132

1.54

1.42

1.2

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

122

1.66

1.42

1.0

1.1

—

COPD

1.77

1.42

1.1

—

Malignant neoplasm of digestive organs

1.94

1.42

1.0

1.1

—

Osteoporosis

2.10

1.40

1.1

1.0

—

Type 1 diabetes

2.17

1.39

1.1

1.0

—

Endometriosis ASRM stages 1,2

2.42

1.39

1.1

—

Acute appendicitis, no complications

118

1.69

1.38

1.1

—

Visual disturbances and blindness

111

1.71

1.38

1.0

1.1

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

1.38

0.0

1.1

—

Paralytic ileus and intestinal obstruction

2.07

1.38

1.0

1.1

—

Deviated nasal septum

1.94

1.37

1.1

1.0

—

Dorsalgia

125

1.50

1.37

1.1

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.84

1.37

1.0

1.1

—

Insulin, intermediate and long-acting

123

1.66

1.37

1.1

—

Benign neoplasm: Rectum

2.20

1.36

1.3

1.0

—

Focal epilepsy

2.19

1.36

1.0

1.1

—

Myeloproliferative diseases (CML excluded)

2.94

1.36

1.4

1.0

—

Other diseases of pancreas

2.94

1.36

1.2

1.1

—

Cardiomyopathies, Primary/intrinsic

2.94

1.36

1.2

1.1

—

Low back pain

124

1.56

1.34

1.1

1.0

—

Endocrine, nutritional and metabolic diseases

1.61

1.34

1.1

1.0

—

Hypotension

2.14

1.33

1.0

1.1

—

Asthma-related infections

125

1.65

1.33

1.1

—

Asthma, hospital admission 2, infections

125

1.65

1.33

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.20

1.33

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.87

1.33

1.1

1.0

—

Other noninfective gastroenteritis and colitis

2.13

1.33

1.0

1.1

—

Intestinal stricture

1.91

1.33

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

165

1.51

1.31

1.1

—

Extrapyramidal and movement disorders

1.81

1.31

1.0

1.1

—

Benign neoplasm of mouth and pharynx

2.50

1.30

1.2

1.0

—

Chalazion

2.50

1.30

1.2

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

2.50

1.30

1.0

—

Superficial injury of head

2.09

1.30

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

2.50

1.30

1.0

—

COPD/asthma/ILD related infections

114

1.49

1.30

1.1

—

COPD/asthma related infections

114

1.49

1.30

1.1

—

Symptoms and signs involving the urinary system

127

1.56

1.30

1.0

1.1

—

Continuous positive airway pressure

2.53

1.29

1.2

1.0

—

Thoracic aortic aneurysm

2.35

1.29

1.0

1.1

—

ILD, hospital admissions

2.35

1.29

1.0

—

Other interstitial pulmonary diseases

2.35

1.29

1.0

—

Interstitial lung disease endpoints

2.35

1.29

1.0

—

Interstitial lung disease

2.35

1.29

1.0

—

Open wound of head

117

1.65

1.28

1.1

—

Diabetic nephropathy

2.32

1.28

1.3

1.1

—

Fracture of lower leg, including ankle

130

0.46

1.28

1.0

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

2.29

1.26

1.0

—

Other dorsopathies, not elsewhere classified

125

1.47

1.24

1.1

1.0

—

Unspecified acute lower respiratory infection

2.40

1.24

1.2

1.0

—

All influenza (not pneumonia)

2.40

1.24

1.0

—

Viral and other specified intestinal infections

2.02

1.24

1.0

—

Fracture of skull and facial bones

2.22

1.24

1.0

—

Abdominal and pelvic pain

120

1.47

1.23

1.1

—

Tinnitus

2.00

1.23

1.3

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

2.00

1.23

1.0

1.1

—

Diabetic retinopathy, excluding more controls

2.16

1.22

1.1

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.76

1.22

1.1

—

Visual disturbances

108

1.67

1.22

1.0

1.1

—

Intracranial injury

124

1.60

1.21

1.1

—

Sequelae of injuries of upper limb

2.63

1.21

1.0

1.1

—

Achilles tendinitis

2.63

1.21

1.4

1.1

—

Cardiomyopathy (excluding other)

2.63

1.21

1.2

—

Explicit bacterial Sepsis

2.63

1.21

1.0

1.1

—

Certain disorders involving the immune mechanism

2.16

1.21

1.0

1.1

—

Other chronic obstructive pulmonary disease

1.74

1.20

1.1

—

Intestinal infectious diseases

162

1.41

1.20

1.0

1.1

—

Headache

1.65

1.20

1.2

1.1

—

Anxiety disorders, excluding more controls

126

1.50

1.20

1.0

1.1

—

Diseases of the ear and mastoid process

146

1.41

1.20

1.2

1.0

—

Chronic periodontitis, complicated

123

1.61

1.19

1.0

1.1

—

Other diseases of urinary system

136

1.45

1.19

1.1

—

Abnormal findings on diagnostic imaging of other body structures

2.31

1.18

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2.31

1.18

1.0

1.1

—

Ulcerative colitis (strict definition, require KELA)

2.31

1.18

1.0

1.1

—

Acute appendicitis

146

1.54

1.18

1.1

—

Melanocytic naevi

1.88

1.17

1.1

1.0

—

Disorders of sclera, cornea, iris and ciliary body

117

1.62

1.17

1.2

1.1

—

Fenamates

0.00

1.16

0.0

1.0

—

Insulin medication

118

1.57

1.16

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

139

1.46

1.16

1.2

1.0

—

Epilepsy

1.92

1.16

1.0

—

Diseases of peritoneum

2.50

1.15

1.0

1.1

—

Other (seronegative) rheumatoid arthritis, wide

2.05

1.15

1.3

1.0

—

Malignant neoplasm of rectum

2.50

1.15

1.0

1.1

—

Focal epilepsy, strict definition

2.05

1.15

1.0

—

Diseases of the respiratory system

1.67

1.15

1.1

—

Use of levodopa decarboxylase inhibitor

2.33

1.12

1.0

—

Adhesive capsulitis of shoulder

2.33

1.12

1.1

1.0

—

Superficial injury of wrist and hand

2.33

1.12

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

110

1.46

1.12

1.0

1.1

—

Diseases of middle ear and mastoid

1.64

1.12

1.1

—

Disorders of vitreous body

107

1.62

1.12

1.1

—

Type 1 diabetes, wide definition

2.00

1.11

1.1

—

Lower back pain or/and sciatica

167

1.41

1.11

1.1

—

Seborrhoeic keratosis

1.96

1.11

1.1

1.0

—

Statin medication

1.56

1.11

1.0

1.1

—

Polymyalgia rheumatica

2.26

1.10

1.0

—

Menorrhagia

1.90

1.10

1.2

1.1

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

2.26

1.10

1.0

—

Fracture of shoulder and upper arm

1.78

1.10

1.0

1.1

—

Other external causes of accidental injury

1.49

1.10

1.1

—

Allergic conjunctivitis

101

1.64

1.09

1.1

—

Cholelithiasis

137

1.46

1.09

1.1

—

L04AA Selective immunosuppressants

1.95

1.08

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

131

1.53

1.08

1.1

—

ILD, hospital admissions 1, main diag only

2.19

1.08

1.0

—

Rheumatoid arthritis

1.82

1.08

1.2

1.1

—

Cholecystitis

2.19

1.08

1.1

1.0

—

Disorders of conjunctiva

148

1.46

1.06

1.1

—

Other diseases of liver

2.12

1.05

1.3

1.1

—

Other obstetric conditions, not elsewhere classified

1.97

1.04

1.0

1.1

—

Genitourinary diseases

1.64

1.04

1.1

—

Other diseases of hard tissues of teeth

1.61

1.03

1.0

1.1

—

Chronic lower respiratory diseases

151

1.38

1.03

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.27

1.03

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.64

1.03

1.1

—

Neurotic, stress-related and somatoform disorders

141

1.44

1.03

1.0

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

2.06

1.02

1.0

1.1

—

Inflammatory bowel disease

1.83

1.02

1.0

1.1

—

Cutaneous abscess, furuncle and carbuncle

1.92

1.02

1.2

1.1

—

Dermatitis and eczema

167

1.37

1.00

1.2

1.0

—

Other and unspecified polyneuropathies, also in other diseases

1.88

1.00

1.1

—

Haemorrhage from respiratory passages

1.77

1.00

1.0

1.1

—

Disorders of vitreous body and globe

110

1.57

1.00

1.1

—

Arthropathies

106

1.43

0.99

1.1

1.0

—

Other symptoms and signs involving cognitive functions and awareness

1.60

0.99

1.0

1.1

—

Malignant neoplasm of bronchus and lung

2.00

0.99

1.0

1.1

—

Triptan medication for migraine, single purchase ok

120

0.56

0.99

1.0

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

120

0.56

0.99

1.0

1.1

—

Early onset COPD

1.84

0.98

1.0

1.1

—

Insulin, fast-acting

1.71

0.98

1.1

—

Anxiety disorders

142

1.42

0.98

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

1.51

0.98

1.1

—

D07AA Corticosteroids, weak (group I)

2.17

0.98

1.2

1.0

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2.17

0.97

1.0

1.1

—

Atrophic disorders of skin

0.00

0.97

0.0

1.0

—

Other diseases of anus and rectum

1.80

0.97

1.0

1.1

—

Other symptoms and signs involving the digestive system and abdomen

1.95

0.97

1.0

1.1

—

Type 1 diabetes, wide definition, subgroup 1

1.94

0.97

1.1

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

1.80

0.96

1.1

—

Use of pramipexole

1.80

0.96

1.1

1.0

—

Other CVD

1.80

0.96

1.0

1.1

—

Asthma, including avohilmo

162

1.35

0.96

1.1

—

Diverticular disease of intestine

104

1.47

0.95

1.2

1.1

—

Insulin, fast-acting or short human

1.69

0.94

1.1

—

Suppurative and unspecified otitis media

1.85

0.94

1.1

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

1.89

0.94

1.1

1.0

—

IBD patients in KELA-register

1.89

0.94

1.0

1.1

—

Appendectomy

127

1.51

0.94

1.1

—

Diabetes, varying definitions

140

1.38

0.93

1.1

—

Noninfectious colitis NAS

2.22

0.93

1.0

—

Adverse effects, not elsewhere classified

2.22

0.93

1.3

1.0

—

Disorders of synovium and tendon

1.57

0.93

1.2

1.0

—

COPD, hospital admission 2, with asthma infections

1.69

0.93

1.1

—

Injuries to the shoulder and upper arm

167

1.40

0.93

1.1

—

Acute upper respiratory infections

153

1.37

0.92

1.1

—

Diabetes mellitus

140

1.38

0.92

1.1

—

Other and unspecified disorders of vitreous body

1.61

0.92

1.0

1.1

—

Other diseases of the digestive system

1.71

0.92

1.2

1.1

—

GI-bleeding

1.71

0.92

1.2

1.1

—

Non-small cell lung cancer, including Hilmo

2.17

0.92

1.2

1.1

—

Accidents

1.44

0.92

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.82

0.92

1.2

1.1

—

Diseases of arteries, arterioles and capillaries

116

1.46

0.92

1.1

—

Primary open-angle glaucoma, strict

1.73

0.92

1.2

1.0

—

Maternal care for known or suspected malpresentation of fetus

2.17

0.92

1.0

1.1

—

Alzheimer disease, including avohilmo

0.49

0.91

1.0

1.1

—

Degenerative macular diseases

2.14

0.91

1.0

—

Other disorders of kidney and ureter

2.14

0.91

1.2

1.0

—

Sarcoidosis

2.14

0.91

1.0

—

Candidiasis

2.14

0.91

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2.14

0.91

1.0

1.1

—

Hernia of abdominal wall, postoperative

2.14

0.91

1.0

—

Mycoses

174

1.40

0.91

1.1

—

Any dementia

0.47

0.91

1.0

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

123

1.45

0.90

1.0

1.1

—

Appendicitis, broad definition

151

1.44

0.90

1.1

—

COPD (mode)

1.83

0.90

1.1

—

Diseases of the skin and subcutaneous tissue

116

1.38

0.89

1.1

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

1.75

0.89

1.1

—

Diseases of appendix

151

1.43

0.89

1.1

—

Acute sinusitis

102

1.54

0.89

1.2

1.0

—

Other respiratory diseases principally affecting the interstitium

1.91

0.88

1.0

1.1

—

Unspecified fall

109

1.54

0.88

1.0

1.1

—

Gout, unspecified

1.86

0.87

1.0

—

Pain in throat and chest

110

1.42

0.87

1.1

—

Pain in joint

1.51

0.87

1.1

1.0

—

Arthrosis

1.45

0.87

1.1

1.0

—

Substance use, excluding alcohol

2.00

0.87

1.3

1.1

—

Exclusions for E4_PCOS_BROAD

2.00

0.87

1.0

—

Other reaction to severe stress, and adjustment disorders

1.72

0.86

1.1

—

Parkinson's disease, strict definition, excluding more controls

1.97

0.85

1.0

1.1

—

Other nutritional deficiencies

128

1.47

0.85

1.2

1.0

—

Disorder of lipoprotein metabolism, unspecified

1.94

0.84

1.0

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.78

0.84

1.1

1.0

—

Migraine

1.68

0.84

1.2

1.0

—

Peripheral arterial reconstruction

1.78

0.84

1.3

1.1

—

Persons encountering health services for examination and investigation

1.48

0.84

1.1

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

135

1.46

0.84

1.1

—

Antihypertensive medication - note that there are other indications

1.55

0.83

1.1

1.0

—

Other diseases of upper respiratory tract

145

1.33

0.83

1.1

—

Benign neoplasm: Colon, unspecified

1.76

0.83

1.1

—

Soft tissue disorders related to use, overuse and pressure

1.75

0.83

1.0

—

Other joint disorders

106

1.39

0.83

1.0

—

Nausea and vomiting

1.75

0.82

1.1

—

Ulcerative colitis

1.74

0.82

1.0

1.1

—

Dental caries, including avohilmo

1.42

0.82

1.1

—

Zoster [herpes zoster]

103

1.53

0.82

1.0

1.1

—

5-aminosalicylic acid

1.88

0.81

1.0

1.1

—

Postpartum care and examination

0.00

0.81

0.0

1.1

—

Other arthrosis

1.50

0.81

1.1

1.0

—

Sleep disorders (combined)

147

1.32

0.81

1.1

—

Other gastritis (incl. Duodenitis)

1.70

0.80

1.1

1.0

—

Exposure to unspecified factor

172

1.34

0.80

1.2

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

163

1.33

0.80

1.0

1.1

—

Presence of other devices

1.70

0.80

1.0

1.1

—

Spontaneous abortion

0.50

0.80

1.0

1.1

—

Other viral diseases, not elsewhere classified

1.69

0.80

1.0

1.1

—

Type 2 diabetes

134

1.35

0.80

1.1

—

Any dementia, excluding more controls

0.50

0.80

1.0

1.1

—

Viral and other specified intestinal infections

1.83

0.79

1.0

—

Dorsopathies

125

1.34

0.79

1.1

1.0

—

Degeneration of macula and posterior pole

1.50

0.79

1.1

—

Amputation

0.00

0.79

0.0

1.0

—

Parkinson's disease, excluding more controls

1.82

0.79

1.0

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1.82

0.79

1.2

1.0

—

Rosacea

0.00

0.79

0.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

1.51

0.78

1.1

—

Dysphagia

1.67

0.78

1.1

—

Puerperal sepsis

0.00

0.78

0.0

1.1

—

Diabetic neuropathy

0.00

0.78

0.0

1.1

—

Ovarian cyst

1.71

0.78

1.2

1.1

—

Undefined dementia

0.00

0.78

0.0

1.0

—

Conjunctivitis

137

1.40

0.77

1.1

—

Bell's palsy

0.00

0.77

0.0

1.0

—

Chondropathies

0.00

0.77

0.0

1.0

—

Codeine or tramadol medication

150

1.31

0.77

1.1

—

Parkinson's disease, strict definition

1.77

0.76

1.0

—

Poisoning by medicine

1.77

0.76

1.0

1.1

—

Ulcer of lower limb, not elsewhere classified

1.77

0.76

1.3

1.1

—

Subarachnoid haemorrhage

0.00

0.76

0.0

1.0

—

Other viral diseases

1.61

0.76

1.0

1.1

—

Other intervertebral disc disorders

119

1.37

0.75

1.1

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.64

0.75

1.1

—

Other acute lower respiratory infections

110

1.47

0.75

1.2

1.1

—

Diseases of the myoneural junction and muscle

2.08

0.74

1.0

—

Aortic aneurysm

1.67

0.74

1.0

1.1

—

Other viral diseases

1.66

0.74

1.0

1.1

—

Lumbar disc prolapse

114

1.41

0.73

1.0

—

Other bacterial intestinal infections

1.84

0.73

1.0

—

Chronic gastritis

1.64

0.73

1.2

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

129

1.36

0.73

1.3

1.0

—

Persons with potential health hazards related to communicable diseases

1.63

0.72

1.0

1.1

—

Follow-up examination after treatment for malignant neoplasms

2.00

0.72

1.2

1.0

—

Herpesviral [herpes simplex] infections

2.00

0.72

1.0

—

Enterocolitis due to Clostridium difficile

2.00

0.72

1.0

—

Pediculosis, acariasis and other infestations

2.00

0.72

1.0

1.2

—

COPD, hospital admissions

1.49

0.72

1.1

—

Inflammatory bowel disease, strict (require KELA)

1.80

0.72

1.0

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1.79

0.72

1.0

—

Viral infections characterized by skin and mucous membrane lesions

172

1.34

0.72

1.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

1.44

0.72

1.1

1.0

—

Glucosamine medication

1.48

0.72

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

136

1.33

0.72

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.62

0.71

1.1

—

Gout, strict definition

1.75

0.71

1.0

1.1

—

Iridocyclitis

1.75

0.71

1.1

1.0

—

Hernia

152

1.32

0.71

1.0

1.1

—

Other and unspecified tonsillitis

1.58

0.70

1.0

1.1

—

Agranulocytosis

1.92

0.70

1.0

—

Adenomyosis (Endometriosis of uterus)

1.92

0.70

1.0

1.1

—

Alcohol use disorder, Swedish definition

115

1.43

0.70

1.0

1.1

—

Single spontaneous delivery

0.53

0.70

1.0

—

Bronchitis

165

1.30

0.70

1.1

—

DVT of lower extremities

1.71

0.70

1.1

1.0

—

Other/unspecified rheumatoid arthritis

1.85

0.68

1.4

1.0

—

Other embolism and thrombosis

1.85

0.68

1.0

—

Implicit viral Sepsis

1.67

0.68

1.0

1.1

—

Viral Sepsis

1.67

0.68

1.0

1.1

—

Other or unspecified ileus, impaction or obstruction

1.67

0.68

1.0

1.1

—

Use of hypnotics and sedatives

151

1.29

0.68

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.52

0.67

1.2

1.1

—

Atrial fibrillation and flutter with reimbursement

1.65

0.67

1.0

—

Gestational [pregnancy-induced] hypertension

1.62

0.66

1.1

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

149

1.30

0.66

1.1

—

Dilated cardiomyopathy

1.79

0.66

1.2

1.0

—

Abnormal involuntary movements

1.79

0.66

1.0

—

Injury of muscle and tendon at lower leg level

1.79

0.66

1.0

1.1

—

Other viral diseases, not elsewhere classified

1.78

0.66

1.0

1.1

—

COPD, early/later onset

1.45

0.66

1.1

—

Rheumatoid arthritis, including avohilmo

1.51

0.66

1.2

1.1

—

Nontoxic goitre/thyroid nodule

1.61

0.65

1.1

—

Injuries to the wrist and hand

166

1.29

0.65

1.2

1.1

—

Chronic laryngitis and laryngotracheitis

1.72

0.64

1.0

—

Retention of urine

1.54

0.64

1.1

—

Female infertility

1.67

0.63

1.0

—

Injuries to the elbow and forearm

143

1.35

0.63

1.0

1.1

—

Sciatica+with lumbago

103

1.43

0.62

1.1

1.0

—

Caries of dentine, including avohilmo

100

1.33

0.62

1.1

—

Cerebrovascular diseases (FINNGEN)

1.62

0.62

1.0

—

Disorders of breast

0.57

0.62

1.2

1.1

—

Disorders of refraction and accommodation

1.63

0.61

1.3

1.0

—

Lesion of ulnar nerve

1.67

0.61

1.2

1.1

—

Pain in thoracic spine

1.67

0.61

1.0

—

Spondyloarthritis

1.67

0.61

1.4

1.1

—

Deep bite

0.00

0.61

0.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

107

1.39

0.60

1.1

—

Other diseases of the respiratory system

1.57

0.60

1.0

1.1

—

Other respiratory disorders and diseases

1.57

0.60

1.0

1.1

—

Prolonged pregnancy

0.00

0.60

0.0

1.1

—

Conjunctivitis (acute, non atopic)

1.56

0.60

1.1

—

Mouth breathing

1.48

0.60

1.0

1.1

—

Pleural plaque with presence of asbestos

0.00

0.60

0.0

1.0

—

Other and unspecified rosacea

0.00

0.60

0.0

1.0

—

Ill-defined and unknown causes of mortality

0.00

0.60

0.0

1.0

—

Abdominal aortic aneurysm (AAA)

0.00

0.60

0.0

1.0

—

Unspecified dementia

0.00

0.59

0.0

1.1

—

Other neurological diseases

136

1.33

0.59

1.2

1.1

—

Spinal stenosis

1.40

0.59

1.2

1.0

—

Neurological diseases, wide definition

1.77

0.59

1.0

—

Erectile dysfunction

0.00

0.59

0.0

1.0

—

Lichen sclerosus et atrophicus

0.00

0.59

0.0

1.0

—

Other disorders of breast

0.00

0.59

0.0

1.0

—

Seropositive rheumatoid arthritis

1.53

0.59

1.3

1.1

—

Disorders of other endocrine glands

1.47

0.59

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.56

0.58

1.0

1.1

—

Multiple delivery

0.00

0.58

0.0

1.0

—

Sudden idiopathic hearing loss

0.00

0.58

0.0

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.58

0.0

1.0

—

Maternal care for other known or suspected fetal problems

1.73

0.58

1.0

1.1

—

Psoriasis vulgaris

1.71

0.57

1.0

1.1

—

Myocardial infarction, unclassifiable

1.49

0.57

1.0

1.1

—

Schizophrenia or delusion

1.48

0.57

1.1

—

Diabetes medication

150

1.26

0.57

1.0

1.1

—

Single delivery by caesarean section

1.64

0.56

1.0

—

Disturbances of skin sensation

1.45

0.56

1.0

—

Schizophrenia, schizotypal and delusional disorders

1.45

0.56

1.1

—

Parkinson's disease

1.62

0.55

1.0

—

Follicular cysts of skin and subcutaneous tissue

1.62

0.55

1.3

1.1

—

Ganglion

1.62

0.55

1.3

1.0

—

Later onset COPD, excluding more controls

1.60

0.55

1.2

1.1

—

Parkinson's disease, including avohilmo

1.58

0.54

1.0

—

Myalgia

1.58

0.54

1.0

—

Gout

1.49

0.54

1.2

1.0

—

Alcohol dependence

1.50

0.54

1.0

1.1

—

Unstable angina pectoris

1.48

0.54

1.2

1.0

—

Artificial joint operation, meniscal resection

149

1.26

0.53

1.0

1.1

—

Blepharochalasis

1.45

0.53

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

106

0.67

0.52

1.1

—

Type of accident

1.52

0.52

1.1

—

Sleep disorders

156

0.74

0.52

1.0

1.1

—

Cellulitis

1.50

0.51

1.0

1.1

—

Organic, including symptomatic, mental disorders

1.36

0.51

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

135

1.33

0.50

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

1.46

0.50

1.0

—

Specific personality disorders

1.46

0.50

1.3

1.0

—

Unspecific neurodegenerative disorder

0.64

0.49

1.0

1.1

—

Dizziness and giddiness

142

1.28

0.49

1.1

—

All anxiety disorders

1.36

0.49

1.0

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.31

0.49

1.0

1.1

—

Bacterial intestinal infections, IBD co-morbidities

1.56

0.48

1.0

—

Cervicobrachial syndrome

1.56

0.48

1.0

—

Inguinal hernia

1.32

0.48

1.1

1.0

—

Insomnia

155

0.75

0.48

1.0

1.1

—

Obesity

123

1.33

0.48

1.2

1.0

—

Benign neoplasm: Sigmoid colon

1.52

0.48

1.0

1.1

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.52

0.48

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

104

1.29

0.48

1.1

1.0

—

Superficial injury of lower leg

1.49

0.47

1.0

1.1

—

Other disorders of ear

153

1.24

0.47

1.2

1.0

—

Other maternal disorders predominantly related to pregnancy

0.67

0.47

1.1

—

Gonarthrosis

1.31

0.47

1.1

1.0

—

Enthesopathies of lower limb, excluding foot

1.46

0.46

1.4

1.0

—

Anxiety (asthma-related co-morbidities)

1.35

0.46

1.0

1.1

—

Diabetic retinopathy

1.46

0.46

1.1

—

Type 2 diabetes, definitions combined

132

1.25

0.46

1.1

—

1.39

0.46

1.1

—

Constipation

150

1.25

0.46

1.0

1.1

—

Obesity and other hyperalimentation

124

1.32

0.46

1.2

1.0

—

Medicines for HER+ breast cancer

0.62

0.46

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

123

1.26

0.45

1.0

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.37

0.45

1.2

1.1

—

Delivery

0.63

0.44

1.0

—

Hyperlipidaemia, other/unspecified

1.40

0.44

1.1

—

Type 2 diabetes, strict (exclude DM1)

133

1.24

0.44

1.1

—

Noninflammatory disorders of female genital tract

1.45

0.44

1.0

1.1

—

Disorders of adult personality and behaviour

1.37

0.44

1.3

1.0

—

Irritable bowel syndrome

1.37

0.44

1.3

1.1

—

Injuries to the ankle and foot

131

1.29

0.43

1.0

1.1

—

130

1.29

0.43

1.0

1.1

—

Malignant neoplasm of colon, including Hilmo

1.61

0.43

1.0

1.1

—

Other and unspecified dermatitis

113

1.33

0.42

1.3

1.1

—

Deforming dorsopathies

1.43

0.42

1.3

1.0

—

Inflammatory diseases of female pelvic organs

1.32

0.42

1.2

1.1

—

Other disorders of conjunctiva

1.56

0.42

1.0

—

Excessive attrition of teeth

122

1.31

0.42

1.0

1.1

—

Cerebrovascular diseases

129

1.25

0.42

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.39

0.42

1.0

—

Conductive and sensorineural hearing loss

130

1.25

0.41

1.3

1.1

—

Schizophrenia or delusion, excluding more controls

1.39

0.41

1.1

—

Gingivitis and periodontal diseases

127

1.22

0.41

1.1

—

Sub-endpoint used in defining T1D endpoints

1.38

0.41

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.38

0.41

1.3

1.1

—

Diagnoses used for exclusion with ILD

1.38

0.41

1.0

1.1

—

Obesity due to excess calories

1.35

0.41

1.2

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.41

0.0

1.1

—

Hordeolum and other deep inflammation of eyelid

0.00

0.41

0.0

1.0

—

Other infective otitis externa

0.00

0.41

0.0

1.1

—

Injury of other and unspecified intrathoracic organs

0.00

0.41

0.0

1.1

—

Excessive vomiting in pregnancy

0.00

0.41

0.0

1.1

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.41

0.0

1.1

—

Amputation of toe

0.00

0.41

0.0

1.1

—

Other contact dermatitis

0.00

0.41

0.0

1.0

—

Twin gestation

0.00

0.41

0.0

1.1

—

Multiple gestation

0.00

0.41

0.0

1.1

—

Postpartum haemorrhage due to retained placenta

0.00

0.41

0.0

1.1

—

Hallux valgus (acquired)

1.44

0.41

1.2

1.1

—

Depression or dysthymia

0.75

0.41

1.2

1.1

—

Pregnancy with abortive outcome

0.73

0.41

1.0

1.1

—

Gout, idiopatic and unspecified

1.36

0.41

1.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis

1.36

0.41

1.3

1.1

—

Benign neoplasm: Adrenal gland

0.00

0.40

0.0

1.1

—

Speech disturbances, not elsewhere classified

0.00

0.40

0.0

1.1

—

Other superficial mycoses

0.00

0.40

0.0

1.1

—

Disorders of skin appendages

105

1.33

0.40

1.1

—

Any mental disorder

142

1.20

0.40

1.1

—

Mycoses

1.33

0.40

1.0

1.1

—

Other appendicitis

0.00

0.40

0.0

1.1

—

Other (not insulin) diabetes medications

142

1.21

0.39

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative

1.40

0.39

1.1

—

Seropositive rheumatoid arthritis, wide

1.31

0.39

1.3

1.1

—

Acute and subacute iridocyclitis

1.43

0.39

1.2

1.0

—

Persistent mood disorders

1.43

0.39

1.0

1.1

—

Other cataract

1.35

0.39

1.2

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.39

0.39

1.1

—

Dermatitis

141

1.27

0.39

1.3

1.0

—

Other ill-defined and unspecified causes of mortality

0.00

0.39

0.0

1.1

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.39

0.0

1.1

—

Injury of muscle and tendon at hip and thigh level

0.00

0.39

0.0

1.1

—

Other diseases of biliary tract

0.00

0.39

0.0

1.1

—

Malignant neoplasm of breast

1.37

0.39

1.1

—

Peripheral artery disease

1.33

0.39

1.2

1.1

—

Psychiatric diseases

129

1.20

0.39

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1.36

0.38

1.1

—

Malignant neoplasm of breast, including Hilmo

1.35

0.38

1.1

—

Substance abuse, excluding more controls

113

1.28

0.38

1.1

—

Other hammer toe(s) (acquired)

1.40

0.38

1.4

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.40

0.38

1.0

1.1

—

Other and unspecified urticaria

1.39

0.38

1.0

1.1

—

Gout, FINNGEN

1.34

0.38

1.2

1.0

—

Excessive, frequent and irregular menstruation

1.30

0.37

1.1

—

Haemorrhoids and perianal venous thrombosis

1.32

0.37

1.0

1.1

—

Pure hypercholesterolaemia

116

1.24

0.37

1.0

1.1

—

Keratitis

1.39

0.36

1.3

1.0

—

Exposure to other specified factors

156

1.24

0.36

1.0

1.1

—

Internal derangement of knee

1.38

0.36

1.1

1.0

—

Pedal cyclist injured in transport accident

1.43

0.35

1.0

1.1

—

Poisoning by drugs, medicaments and biological substances

1.43

0.35

1.0

—

Erosion of teeth , including avohilmo

1.43

0.35

1.0

—

Hernia of abdominal wall

1.31

0.35

1.1

—

Female infertility, cervical, vaginal, other or unspecified origin

1.39

0.35

1.0

—

False labour

1.39

0.35

1.0

1.1

—

Cough

1.35

0.35

1.0

1.1

—

Transient ischemic attack

109

1.26

0.34

1.1

—

Cystitis

123

1.21

0.34

1.0

1.1

—

Disorders of parathyroid gland

1.35

0.34

1.2

1.1

—

Mental and behavioural disorders due to psychoactive substance use

134

1.24

0.34

1.1

—

Injuries to the thorax

100

1.30

0.33

1.0

1.1

—

Meniscus derangement

1.27

0.33

1.1

1.0

—

Other fall from one level to another

1.30

0.33

1.0

1.1

—

Disease of hard tissues of teeth, NOS

1.29

0.33

1.1

—

Diseases of the musculoskeletal system and connective tissue

1.30

0.32

1.1

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

109

1.25

0.32

1.1

—

malignant neoplasm of male genital organs

1.38

0.32

1.0

1.1

—

Other headache syndromes

1.35

0.32

1.0

1.1

—

Acute alcohol intoxication

1.35

0.31

1.0

1.1

—

Functional dyspepsia

1.35

0.31

1.4

1.0

—

Pre-eclampsia or poor fetal growth

1.32

0.30

1.0

1.1

—

Candidiasis

1.30

0.30

1.0

—

Umbilical hernia

1.27

0.30

1.0

1.1

—

Other enthesopathies

1.25

0.29

1.1

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.34

0.29

1.1

1.0

—

Acute bronchitis

1.30

0.28

1.3

1.1

—

Atopic dermatitis

1.24

0.28

1.2

1.0

—

Combinations of oral blood glucose lowering drugs

1.23

0.27

1.1

1.0

—

Excessive earwax

125

0.78

0.27

1.2

1.1

—

Stroke, including SAH

117

0.81

0.26

1.2

1.1

—

Diseases of salivary glands

1.19

0.26

1.0

1.1

—

Fracture of femur

1.19

0.26

1.0

1.1

—

Fracture at wrist and hand level

0.68

0.26

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

130

1.20

0.25

1.1

—

Fitting and adjustment of other devices

1.23

0.25

1.1

—

Substance abuse

133

1.20

0.25

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

1.18

0.24

1.0

1.1

—

Urticaria and erythema

1.18

0.24

1.0

1.1

—

Other disorders of veins

0.74

0.24

1.5

1.0

—

Cardiodefibrillation

1.26

0.24

1.1

—

Missing teeth due to accident, extraction or parodontitis

139

0.81

0.24

1.0

1.1

—

129

1.19

0.23

1.0

1.1

—

Antenatal screening

1.28

0.23

1.0

1.1

—

Hyperparathyroidism

1.30

0.23

1.2

1.1

—

Other specific joint derangements/joint disorders

104

1.18

0.23

1.1

1.0

—

Anterior Iridocyclitis

1.28

0.23

1.2

1.1

—

Migraine with aura

1.28

0.23

1.4

1.0

—

Sulfonylureas

0.76

0.22

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

132

1.15

0.22

1.1

—

COPD related to multimorbidity

1.24

0.22

1.1

—

Injuries to the neck

1.22

0.22

1.6

1.0

—

Otitis externa

1.22

0.22

1.2

1.1

—

Sensorineural hearing loss

129

1.16

0.22

1.3

1.1

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

0.21

0.0

1.1

—

Suicide or other Intentional self-harm

1.19

0.21

1.0

1.1

—

Myocardial infarction, with ST-elevation

1.19

0.21

1.0

1.1

—

0.00

0.21

0.0

1.0

—

Complications following abortion and ectopic and molar pregnancy

0.00

0.21

0.0

1.0

—

Maternal care for cervical incompetence

0.00

0.21

0.0

1.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

0.21

0.0

1.0

—

Extreme obesity with alveolar hypoventilation

0.00

0.21

0.0

1.1

—

Gluteal tendinitis

0.00

0.21

0.0

1.0

—

Other and unspecified abdominal hernia

0.00

0.21

0.0

1.1

—

Normal-pressure hydrocephalus

0.00

0.21

0.0

1.0

—

Somnolence, stupor and coma

0.00

0.21

0.0

1.1

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.21

0.0

1.0

—

Embolic stroke

0.00

0.21

0.0

1.0

—

Lesion of lateral popliteal nerve

0.00

0.21

0.0

1.1

—

Chronic iridocyclitis

0.00

0.21

0.0

1.0

—

Other neurotic disorders

0.00

0.21

0.0

1.1

—

Impotence

0.00

0.21

0.0

1.1

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

0.21

0.0

1.0

—

Other orthopaedic follow-up care

0.00

0.21

0.0

1.0

—

Arterial embolism and thrombosis

0.00

0.21

0.0

1.0

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.21

0.0

1.1

—

Other osteochondropathies

0.00

0.21

0.0

1.1

—

MS-disease / Multiple Sclerosis

0.00

0.21

0.0

1.0

—

Acute gastritis

0.00

0.21

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

1.1

—

Disturbance of activity and attention

0.00

0.21

0.0

1.0

—

Hyperkinetic disorders

0.00

0.21

0.0

1.0

—

Atypical facial pain

0.00

0.21

0.0

1.0

—

Sequelae of other external causes

0.00

0.21

0.0

1.0

—

Cerebral cysts

0.00

0.21

0.0

1.1

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.21

0.0

1.1

—

Leiomyoma of uterus

1.19

0.21

1.2

1.1

—

Mental and behavioural disorders due to alcohol

112

1.20

0.21

1.0

1.1

—

Glaucoma-related operations

0.00

0.21

0.0

1.1

—

Thyrotoxicosis with toxic multinodular goitre

0.00

0.21

0.0

1.0

—

Cysts of oral region, not elsewhere classified

0.00

0.21

0.0

1.1

—

Personal history of malignant neoplasm

0.00

0.21

0.0

1.0

—

LSIL lesion of the cervix uteri

0.00

0.21

0.0

1.1

—

Tonsillectomy and adenotomy

0.78

0.20

1.0

1.1

—

Laparoscopic right hemicolectomy

0.00

0.20

0.0

1.1

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

0.20

0.0

1.1

—

Special screening examination for neoplasms

0.00

0.20

0.0

1.0

—

Other otitis externa (chronic)

0.00

0.20

0.0

1.1

—

Inflammatory disorders of breast

0.00

0.20

0.0

1.0

—

Bronchitis, not specified as acute or chronic

0.00

0.20

0.0

1.1

—

Vascular disorders of the intestines

0.00

0.20

0.0

1.1

—

Fibroblastic disorders

1.25

0.20

1.5

1.0

—

Gastroduodenal ulcer

1.20

0.19

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

141

0.88

0.19

1.0

1.1

—

Subjective visual disturbances

1.18

0.19

1.0

1.1

—

Ventral hernia

1.15

0.19

1.2

1.1

—

Herpesviral [herpes simplex] infections

1.15

0.19

1.0

—

Postmenopausal bleeding

1.24

0.19

1.0

1.1

—

Female genital prolapse

1.24

0.19

1.0

1.1

—

Other extrapyramidal and movement disorders in other diseases

1.13

0.18

1.0

—

Chronic diseases of tonsils and adenoids

111

0.85

0.18

1.0

—

Oxicams

1.20

0.18

1.0

—

Polyp of the female genital tract

1.15

0.18

1.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.15

0.17

1.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

1.15

0.17

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.15

0.17

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

106

0.84

0.17

1.2

1.1

—

Coxibs

1.20

0.17

1.0

—

Acetic acid derivatives and related substances

1.19

0.17

1.0

—

Artrosis, including avohilmo

122

1.12

0.17

1.1

1.0

—

Obesity related asthma

1.18

0.16

1.1

—

Kela-code for severe mental illness

1.16

0.16

1.0

1.1

—

Benzodiazepine use

177

0.89

0.16

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

160

0.89

0.16

1.0

1.1

—

Diseases of external ear

1.13

0.16

1.1

—

Pregnancy hypertension

1.12

0.16

1.1

—

STROKE

1.18

0.16

1.1

1.0

—

Coxarthrosis, primary

128

0.86

0.15

1.2

1.1

—

Cervical disc disorders

0.76

0.15

1.0

1.1

—

Spondylosis

106

1.15

0.15

1.2

1.0

—

Temporomandibular joint disorders, including avohilmo

1.20

0.15

1.1

—

Unspecified mental disorder

1.11

0.15

1.1

—

Stroke, excluding SAH

110

0.86

0.15

1.2

1.1

—

Recurrent or chronic depression

1.09

0.15

1.0

1.1

—

Papulosquamous disorders

1.10

0.15

1.0

1.1

—

N06DA Anticholinesterases

0.79

0.14

1.0

1.1

—

Use of anticholinesterases

0.79

0.14

1.0

1.1

—

Alcohol use disorder, ICD-based

1.18

0.14

1.0

1.1

—

Triptan medication for migraine, min. 3 purchases

0.79

0.13

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

113

1.14

0.13

1.1

—

Chronic apical periodontitis

162

1.09

0.13

1.1

—

Fracture of forearm

112

1.14

0.13

1.0

1.1

—

Dementia

0.81

0.13

1.0

1.1

—

Irregular menses

1.17

0.13

1.3

1.0

—

Polycystic ovarian syndrome, consortium definition

0.87

0.12

1.2

1.1

—

In situ neoplasms

1.18

0.12

1.0

1.1

—

Necrosis of pulp, including avohilmo

126

0.87

0.11

1.0

1.1

—

Transport accidents

1.15

0.11

1.2

1.1

—

Chronic sinusitis

1.16

0.10

1.2

1.1

—

Nerve, nerve root and plexus disorders

165

1.08

0.10

1.1

—

External causes of morbidity and mortality

1.12

0.10

1.0

1.1

—

Zoster [herpes zoster]

1.14

0.10

1.0

—

Polyuria

1.14

0.10

1.0

1.1

—

Personality disorders, excluding more controls

1.11

0.09

1.4

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.08

0.09

1.0

—

Injuries to the hip and thigh

1.13

0.09

1.0

1.1

—

Fissure and fistula of anal and rectal regions

1.04

0.09

1.0

1.1

—

Other menopausal disorders

1.13

0.09

1.0

—

Carpal tunnel syndrome

128

1.10

0.09

1.1

—

Psoriasis

1.07

0.08

1.0

1.1

—

Fracture of lumbar spine and pelvis

1.07

0.08

1.0

1.1

—

Actinic keratosis

1.14

0.08

1.1

—

Infections with a predominantly sexual mode of transmission

1.03

0.08

1.0

1.1

—

Colonic or urogenital fistula

0.82

0.08

1.0

1.1

—

Gonarthrosis, primary, with knee surgery

116

1.10

0.08

1.0

1.1

—

Biguanides

148

1.07

0.08

1.1

—

Fracture of rib(s), sternum and thoracic spine

1.09

0.08

1.0

1.1

—

Obesity, other/unspecified

1.09

0.08

1.0

1.1

—

1.07

0.08

1.1

1.0

—

Benign lipomatous neoplasm

1.08

0.08

1.3

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

0.84

0.08

1.0

—

Propionic acid derivatives

0.84

0.08

1.0

—

Pregnancy, childbirth and the puerperium

0.80

0.08

1.0

1.1

—

Benign paroxysmal vertigo

0.84

0.07

1.0

1.1

—

Vasomotor and allergic rhinitis

0.82

0.07

1.0

1.1

—

Medical abortion

0.90

0.07

1.1

—

Later onset COPD

0.86

0.07

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.06

0.07

1.0

1.1

—

Contraceptive management

0.88

0.07

1.0

1.1

—

Other diseases of lip and oral mucosa

1.02

0.07

1.1

—

Sequelae of cerebrovascular disease

0.88

0.07

1.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

1.12

0.06

1.1

—

Gonarthrosis,primary

145

1.06

0.06

1.1

—

Open wound of wrist and hand

101

0.87

0.06

1.2

1.0

—

Injuries to the knee and lower leg

170

1.04

0.05

1.1

—

Dental pulpitis, including avohilmo

144

0.95

0.04

1.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

100

1.09

0.04

1.0

—

Presence of other functional implants

1.08

0.04

1.0

1.1

—

Spondylopathies

114

0.94

0.04

1.1

1.0

—

Primary gonarthrosis, bilateral

112

1.07

0.03

1.1

—

Fall on same level involving ice and snow

131

1.07

0.03

1.1

—

1.09

0.03

1.1

—

Diseases of male genital organs

0.93

0.03

1.0

1.1

—

Other antidepressants

143

0.97

0.02

1.1

—

Persons encountering health services in circumstances related to reproduction

0.94

0.02

1.0

1.1

—

Other disorders of urethra and urinary system

121

0.95

0.02

1.1

—

Coxarthrosis, primary, with hip surgery

106

1.06

0.01

1.2

1.1

—

Coxarthrosis

0.94

0.01

1.1

1.0

—

Coxarthrosis [arthrosis of hip](FG)

0.95

0.01

1.1

1.0

—

Depression

158

1.03

0.01

1.1

—

Caries of enamel

147

1.03

0.00

1.0

1.1

—

Diseases of inner ear

121

0.96

0.00

1.0

1.1

—

Mood disorders

165

0.98

0.00

1.1

—

Selective serotonin reuptake inhibitors

143

0.99

0.00

1.1

—

Disorders of vestibular function (Vertigo)

103

0.95

0.00

1.0

1.1

—

Dementia, including avohilmo

1.01

0.00

1.1

—

Complications of labour and delivery

0.96

0.00

1.0

1.1

—

Mood [affective] disorders

165

0.98

0.00

1.1

—

Cholecystectomy

151

0.97

0.00

1.1

—

Periapical abscess

1.03

0.00

1.1

—

Mood disorders, excluding more controls

137

1.00

0.00

1.1

—

Use of ropinirole

0.00

0.0

1.0

—

Chondrocostal junction syndrome [Tietze]

0.00

0.0

1.0

—

Cluster headache, strict

0.00

0.0

1.0

—

Pustular psoriasis

0.00

0.0

1.0

—

Intermittent heterotropia

0.00

0.0

1.0

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.0

1.0

—

Gonococcal infection

0.00

0.0

1.0

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

Other spirochaetal diseases

0.94

0.00

1.0

1.1

—

Chronic tubulo-interstitial nephritis

0.00

0.0

1.0

—

Unspecified chronic bronchitis

0.00

0.0

1.2

—

Personality disorders

1.00

0.00

1.4

1.0

—

Spirochaetal infections, other/unspecified

0.94

0.00

1.0

1.1

—

Contact with heat and hot substances

0.00

0.0

1.0

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

0.0

1.0

—

Hypermobility syndrome

0.00

0.0

1.0

—

Other spirochaetal diseases

0.94

0.00

1.0

1.1

—

Other and unspecified disease of Bartholin gland

0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

0.0

1.0

—

Scar conditions and fibrosis of skin

0.00

0.0

1.0

—

Contusion of ankle

0.00

0.0

1.0

—

Intestinal malabsorption

0.00

0.0

1.0

—

Other diseases of spinal cord

0.00

0.0

1.0

—

Pustulosis palmaris et plantaris

0.00

0.0

1.0

—

Urticaria

1.02

-0.00

1.0

1.1

—

Vascular dementia (undefined)

0.00

-0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

1.0

—

Occupational exposure to risk-factors

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Early onset)

0.00

-0.00

0.0

1.0

—

Other and unspecified follicular disorders

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.0

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

1.1

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.0

—

Residual foreign body in soft tissue

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Urolithiasis

0.99

-0.00

1.0

1.1

—

Prepatellar bursitis

0.00

-0.00

0.0

1.0

—

Disorders of acoustic nerve

0.00

-0.00

0.0

1.0

—

Spinal instabilities

0.00

-0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

1.0

—

Amputation of thigh

0.00

-0.00

0.0

1.0

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

1.0

—

Other specified/unspecified spondylopathies

0.00

-0.00

0.0

1.0

—

Other specified/unspecified inflammatory spondylopathies

0.00

-0.00

0.0

1.1

—

Chronic hepatitis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Inguinal hernia, unilateral

0.00

-0.00

0.0

1.0

—

Tobacco use

0.00

-0.00

0.0

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.02

-0.00

1.2

1.1

—

Contact with and exposure to communicable diseases

0.89

-0.00

1.0

1.1

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.2

—

Other/unspecified dorsalgia

0.93

-0.00

1.1

—

Other general symptoms and signs

0.00

-0.00

0.0

1.0

—

Hyperplasia of prostate

1.00

-0.00

1.0

1.1

—

Calculus of kidney and ureter

0.87

-0.00

1.0

1.1

—

Muscle strain

0.00

-0.00

0.0

1.0

—

Amputation of foot

0.00

-0.00

0.0

1.0

—

Vascular diseases of the intestine

0.00

-0.00

0.0

1.0

—

Gonococcal infection

0.00

-0.00

0.0

1.0

—

Juvenile arthritis (FINNGEN)

0.00

-0.00

0.0

1.0

—

Noise effects on inner ear

0.00

-0.00

0.0

1.2

—

Motor neuron disease

0.00

-0.00

0.0

1.2

—

Nontoxic diffuse goitre

0.00

-0.00

0.0

1.0

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

Systemic sclerosis (FG)

0.00

-0.00

0.0

1.0

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

Other abnormal findings of blood chemistry

0.00

-0.00

0.0

1.0

—

Inguinal of femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Other intracranial haemorrhages

0.00

-0.00

0.0

1.0

—

Other other unspecified disorders of the circulatory system

0.00

-0.00

0.0

1.0

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

1.0

—

Spasmodic torticollis

0.00

-0.00

0.0

1.0

—

Lyme disease

0.95

-0.00

1.0

1.1

—

Hypertrophic scar

0.00

-0.00

0.0

1.0

—

Other specified disorders of kidney and ureter

0.00

-0.00

0.0

1.0

—

Femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of ankle and foot

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of wrist and hand

0.00

-0.00

0.0

1.0

—

Radial styloid tenosynovitis [de Quervain]

0.00

-0.00

0.0

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.00

-0.00

1.1

—

Other vitreous opacities

0.00

-0.00

0.0

1.0

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

1.0

—

Infections with a predominantly sexual mode of transmission

0.97

-0.00

1.0

—

Status epilepticus

0.00

-0.00

0.0

1.1

—

Hyperkinetic disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Cranial nerves

0.00

-0.00

0.0

1.0

—

Subacute thyroiditis

0.00

-0.00

0.0

1.0

—

Motor neuron disease (with DMD)

0.00

-0.00

0.0

1.2

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

-0.00

0.0

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.86

-0.00

1.0

1.1

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.1

—

Other and unspecified mononeuropathies of upper limb

0.00

-0.00

0.0

1.0

—

Other hearing loss

0.86

-0.00

1.2

1.1

—

Other abnormal products of conception

1.02

-0.00

1.0

1.1

—

Other facial nerve disorders

0.00

-0.00

0.0

1.0

—

Erosion and ectropion of cervix uteri

0.00

-0.00

0.0

1.0

—

COPD, hospital admissions 1, only main diagnosis

1.00

-0.00

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

-0.00

0.0

1.0

—

Medial epicondylitis

0.00

-0.00

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

-0.00

0.0

1.0

—

Ulcer of vagina/vulva

0.00

-0.00

0.0

1.0

—

Striking against or struck by other objects

0.92

-0.00

1.0

1.1

—

Other benign neoplasms of skin

0.94

-0.00

1.3

1.1

—

Carcinoma in situ of other and unspecified genital organs

0.00

-0.00

0.0

1.0

—

Other juvenile arthritis

0.00

-0.00

0.0

1.0

—

Meralgia paraesthetica

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.0

—

Ulcerative proctitis

0.00

-0.00

0.0

1.1

—

Psoriasis (vulgaris), strict definition

0.00

-0.00

0.0

1.0

—

Other specified/unspecified dorsopathies

0.00

-0.00

0.0

1.0

—

Car occupant injured in noncollision transport accident

0.00

-0.00

0.0

1.0

—

Serous carcinoma of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.0

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

-0.00

0.0

1.0

—

Other and unspecified mononeuropathies, also in other diseases

0.00

-0.00

0.0

1.0

—

Use of biperiden

0.00

-0.00

0.0

1.1

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

1.0

—

Diaphragmatic hernia

0.98

-0.00

1.0

1.1

—

Non-selective monoamine reuptake inhibitors

0.90

-0.00

1.1

—

L04AC Interleukin inhibitors

0.00

-0.00

0.0

1.0

—

Contact with nonpowered hand tool

0.00

-0.00

0.0

1.2

—

Atopic dermatitis, strict definition with reimbursement

0.93

-0.00

1.2

1.0

—

Cluster headache, wide

0.00

-0.00

0.0

1.0

—

Abnormal serum enzyme levels

0.97

-0.00

1.0

1.1

—

Preterm labour and delivery

1.02

-0.00

1.0

1.1

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

-0.00

0.0

1.0

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

-0.00

0.0

1.0

—

Unspecified jaundice

0.00

-0.00

0.0

1.1

—

Carcinoma in situ, bladder

0.00

-0.00

0.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS